GlassScriptPhysician profile
Douglas C Miller
NPI 1073596193
$954.79
in general payments reported to CMS, 2019-2025
19 companies · $365 in 2025
The $365 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.95 · 2020: $29.15 · 2021: $60.57 · 2022: $61.43 · 2023: $86.17 · 2024: $300 · 2025: $365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $733 · Education: $17.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $732.98 |
| Education | $17.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spirair, INC. | $253.83 | 2024-2025 | Septalign |
| Regeneron Healthcare Solutions, INC. | $155.06 | 2023-2025 | Dupixent |
| Glaxosmithkline, LLC. | $61.38 | 2022-2025 | Nucala |
| Inspire Medical Systems, INC. | $48.42 | 2024-2025 | Inspire |
| Integra Lifesciences Corporation | $48.13 | 2020-2024 | Relieva Spinplus Nav, Inspira Air, Acclarent Aera |
| Idorsia Pharmaceuticals US INC | $43.51 | 2023-2024 | Quviviq |
| Boston Scientific Corporation | $42.69 | 2019-2025 | General - Therapies |
| Cochlear Americas | $40.34 | 2020-2022 | |
| Stryker Corporation | $36.21 | 2019 | |
| Aerin Medical INC. | $32.57 | 2025 | |
| Medtronic, INC. | $25.28 | 2025 | Stealthstation S8 Platform |
| Acera Surgical, INC. | $24.47 | 2025 | Restrata Wound Matrix |
| Intersect Ent, INC. | $23.87 | 2021 | |
| Acclarent, INC | $22.60 | 2023 | Trudi Nav Cable |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.92 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $19.23 | 2023 | |
| Novo Nordisk INC | $18.72 | 2021 | |
| Davol INC. | $18.58 | 2025 | Arista |
| Ambu INC. | $17.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.